Adipomyokines in children with obesity
https://doi.org/10.14341/probl13250
Abstract
BACKGROUND: Adipomyokines are synthesized and secreted into the bloodstream by cells of both muscle and adipose tissue. They can have both a negative metabolic effect, acting as pro-inflammatory adipokines in obesity, and a positive one, increasing in response to physical exertion in the form of myokines.
AIM: To study the features of adipocytokine secretion in children with constitutionally exogenous obesity.
MATERIALS AND METHODS: The study included 80 patients: 60 adolescents aged 15 [13; 16] years with constitutionally exogenous obesity SDS BMI: 3.0 [2.6; 3.3] and 20 control group children aged 16 [15; 17] years without excess weight SDS BMI: -0.3 [-1.25; 0.33]. Commercial enzyme immunoassay kits were used to determine the level of adipomyokines. The compositional composition of the body was evaluated by bioimpedance analysis (InBody 770 analyzer, South Korea) in the morning, on an empty stomach. Statistical processing was carried out using STATISTICA v.12.0 (StatSoft Inc., USA). The results are presented in the form of median (Me) and quartiles (Q1; Q3) corresponding to 25 and 75 percentiles. The critical significance level (p) was assumed to be <0.05.
RESULTS: Levels of IL-6 and irisin are statistically significantly higher in obese adolescents compared to the control group: 0.55 [0.226; 1.35] pg/ml vs 0.202 [0.128; 0.652] pg/ml (p=0.041) and 11.16 [6.6; 22.76] mcg/ml vs 7.36 [6.48; 9.68] mcg/ml (p=0.043), respectively. Concentrations of IL-6, myostatin and decorin increase with an increase in the degree of obesity: grade I vs III: 0.226 [0.224; 0.398] vs 0.80 [0.36; 1.81] pg/ml (p=0,0197), 25,85 [21,53; 28,23] vs 31.41 [24.36; 35.06] ng/ml (p=0.03), 4065.3 [3244.9; 5245.5] vs 5322.5 [4199.8; 7702.4] pg/ml (p=0.0376), respectively. In obese children, IL-6 levels positively correlate with BMI, SDS BMI and the amount of adipose tissue, and myostatin — with BMI and SDS BMI. The concentration of irisin in the blood serum is significantly higher in obese girls than in obese boys and healthy girls. Obese patients, compared with lean peers, are characterized by a statistically significantly higher content of both fat and lean mass. With the progression of obesity, there is a statistically significant increase in the ratio of fat to lean mass (I degree — 0.66 [0.56; 0.7], III — 0.78 [0.68; 0.98] (p=0.0073).
CONCLUSION: Patients with obesity and normal body weight have different levels of adipomyokines. An increase in the level of IL-6 with the progression of obesity is directly related to an increase in the content of adipose tissue. Further study of the features of adipocytokine secretion, their relationship with the features of the body composition and metabolic complications in obesity is required.
Keywords
About the Authors
Yu. V. BurmitskayaRussian Federation
Yulia V. Burmitskaya, MD
11 Dm. Ulyanova street, 117036 Moscow, Russia
Competing Interests:
нет
O. V. Vasyukova
Russian Federation
Olga V. Vasyukova, MD, PhD
11 Dm. Ulyanova street, 117036 Moscow, Russia
Competing Interests:
нет
P. L. Okorokov
Russian Federation
Pavel L. Okorokov, MD, PhD
11 Dm. Ulyanova street, 117036 Moscow, Russia
Competing Interests:
нет
Z. T. Zuraeva
Russian Federation
Zamira T. Zuraeva, MD
11 Dm. Ulyanova street, 117036 Moscow, Russia
Competing Interests:
нет
O. B. Bezlepkina
Russian Federation
Olga B. Bezlepkina, MD, PhD, Professor
11 Dm. Ulyanova street, 117036 Moscow, Russia
Competing Interests:
нет
References
1. Pedersen BK, Steensberg A, Fischer C, et al. Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil. 2003;24(2-3):113-119. doi: https://doi.org/10.1023/a:1026070911202
2. Severinsen MCK, Pedersen BK. Muscle–organ crosstalk: The emerging roles of myokines. Endocr Rev. 2020;41(4):594-609. doi: https://doi.org/10.1210/endrev/bnaa016
3. Peterkova VA, Bezlepkina OB, Bolotova NV, et al. Clinical guidelines «Obesity in children». Problems of Endocrinology. 2021;67(5):67-83. (In Russ.). doi: https://doi.org/10.14341/probl12802
4. Gätjens I, Schmidt SCE, Plachta-Danielzik S, et al. Body composition characteristics of a load-capacity model: Age-dependent and sex-specific percentiles in 5- to 17-year-old children. Obes Facts. 2021;14(6):593-603. doi: https://doi.org/10.1159/000518638
5. Choi KM. Sarcopenia and sarcopenic obesity. Korean J Intern Med. 2016;31(6):1054-1060. doi: https://doi.org/10.3904/kjim.2016.193
6. Okorokov PL, Vasyukova OV. Features of body composition and basal metabolic rate in adolescents with morbid obesity. Pediatria n.a. G.N. Speransky. 2021;100(4):216-221. (In Russ.).
7. Okorokov PL, Vasyukova OV, Bezlepkina OB. Sarcopenic obesity prevalence in children with constitutional-exogenous obesity. Pediatria n.a. G.N. Speransky. 2022;101(5):43-49. (In Russ.). doi: https://doi.org/10.24110/0031-403X-2022-101-5-43-49
8. Luciardi MC, Carrizo TR, Díaz EI, et al. Estado proinflamatorio en niños obesos [Proinflammatory state in obese children]. Rev Chil Pediatr. 2018;89(3):346-351. doi: https://doi.org/10.4067/S0370-41062018005000501
9. Hosick P, McMurray R, Hackney AC, et al. Resting IL-6 and TNF-α level in children of different weight and fitness status. Pediatr Exerc Sci. 2013;25(2):238-247. doi: https://doi.org/10.1123/pes.25.2.238
10. Pîrsean C, Neguț C, Stefan-van Staden RI, et al. The salivary levels of leptin and interleukin-6 as potential inflammatory markers in children obesity. PLoS One. 2019;14(1):e0210288. doi: https://doi.org/10.1371/journal.pone.0210288
11. Tam CS, Garnett SP, Cowell CT, et al. IL-6, IL-8 and IL-10 levels in healthy weight and overweight children. Horm Res Paediatr. 2010;73(2):128-134. doi: https://doi.org/10.1159/000277632
12. El-Mikkawy DME, EL-Sadek MA, EL-Badawy MA, Samaha D. Circulating level of interleukin-6 in relation to body mass indices and lipid profile in Egyptian adults with overweight and obesity. Egypt Rheumatol Rehabil. 2020;47(1):7. doi: https://doi.org/10.1186/s43166-020-00003-8
13. Khaodhiar L, Ling P-R, Blackburn GL, Bistrian BR. Serum levels of Interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. J Parenter Enter Nutr. 2004;28(6):410-415. doi: https://doi.org/10.1177/0148607104028006410
14. Baikpour M, Baikpour M, Hosseini M, Sarveazad A. Variations in levels of interleukins and adiponectin in normal and obese adults; a case-control study. J Med Physiol. 2017; 2(2):56-62. [cited 20.07.2023]. Available from: http://jphysiology.com/index.php/jmp/article/view/29
15. Roytblat L, Rachinsky M, Fisher A, et al. Raised interleukin-6 levels in obese patients. Obes Res. 2000;8(9):673-675. doi: https://doi.org/10.1038/oby.2000.86
16. Hittel DS, Berggren JR, Shearer J, et al. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes. 2009;58(1):30-38. doi: https://doi.org/10.2337/db08-0943
17. Milan G, Dalla Nora E, Pilon C, et al. Changes in muscle myostatin expression in obese subjects after weight loss. J Clin Endocrinol Metab. 2004;89(6):2724-2727. doi: https://doi.org/10.1210/jc.2003-032047
18. Park JJ, Berggren JR, Hulver MW, et al. GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Physiol Genomics. 2006;27(2):114-121. doi: https://doi.org/10.1152/physiolgenomics.00045.2006
19. Amor M, Itariu BK, Moreno-Viedma V, et al. Serum myostatin is upregulated in obesity and correlates with insulin resistance in humans. Exp Clin Endocrinol Diabetes. 2019;127(8):550-556. doi: https://doi.org/10.1055/a-0641-5546
20. Wang F, Liao Y, Li X, Ren C, Cheng C, Ren Y. Increased circulating myostatin in patients with type 2 diabetes mellitus. J Huazhong Univ Sci Technolog Med Sci. 2012;32(4):534-539. doi: https://doi.org/10.1007/s11596-012-0092-9
21. Efthymiadou A, Vasilakis IA, Giannakopoulos A, Chrysis D. Myostatin serum levels in children with type 1 diabetes mellitus. Hormones (Athens). 2021;20(4):777-782. doi: https://doi.org/10.1007/s42000-021-00317-y
22. Baumgartner M, Lischka J, Schanzer A, et al. Plasma myostatin increases with age in male youth and negatively correlates with vitamin d in severe pediatric obesity. Nutrients. 2022;14(10):2133. doi: https://doi.org/10.3390/nu14102133
23. Ambroszkiewicz J, Chełchowska M, Mazur J, et al. Relationships between body weight status and serum levels of adipokine, myokine and bone metabolism parameters in healthy normal weight and thin children. J Clin Med. 2022;11(14):4013. doi: https://doi.org/10.3390/jcm11144013
24. Bolton K, Segal D, McMillan J, et al. Decorin is a secreted protein associated with obesity and type 2 diabetes. Int J Obes (Lond). 2008;32(7):1113-1121. doi: https://doi.org/10.1038/ijo.2008.41
25. Palacios-González B, Vadillo-Ortega F, Polo-Oteyza E, et al. Irisin levels before and after physical activity among school-age children with different BMI: a direct relation with leptin. Obesity (Silver Spring). 2015;23(4):729-732. doi: https://doi.org/10.1002/oby.21029
26. Çatlı G, Küme T, Tuhan HÜ, et al. Relation of serum irisin level with metabolic and antropometric parameters in obese children. J Diabetes Complications. 2016;30(8):1560-1565. doi: https://doi.org/10.1016/j.jdiacomp.2016.07.019
27. Blüher S, Panagiotou G, Petroff D, et al. Effects of a 1-year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children. Obesity (Silver Spring). 2014;22(7):1701-1708. doi: https://doi.org/10.1002/oby.20739
28. Jang HB, Kim H-J, Kang JH, et al. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents. Metabolism. 2017;73(8):100-108. doi: https://doi.org/10.1016/j.metabol.2017.05.007
29. Löffler D, Müller U, Scheuermann K, et al. Serum irisin levels are regulated by acute strenuous exercise. J Clin Endocrinol Metab. 2015;100(4):1289-1299. doi: https://doi.org/10.1210/jc.2014-2932
30. Stengel A, Hofmann T, Goebel-Stengel Met al. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – Correlation with body mass index. Peptides. 2013;39(8):125-130. doi: https://doi.org/10.1016/j.peptides.2012.11.014
31. Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61(12):1725-1738. doi: https://doi.org/10.1016/j.metabol.2012.09.002
32. Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98(4):E769-778. doi: https://doi.org/10.1210/jc.2012-2749
Supplementary files
|
1. Figure 1. IL-6 levels in obese adolescents and controls. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(105KB)
|
Indexing metadata ▾ |
|
2. Figure 2. The level of IL-6 in adolescents with different degrees of obesity and control groups. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(140KB)
|
Indexing metadata ▾ |
Review
For citations:
Burmitskaya Yu.V., Vasyukova O.V., Okorokov P.L., Zuraeva Z.T., Bezlepkina O.B. Adipomyokines in children with obesity. Problems of Endocrinology. 2023;69(4):87-95. (In Russ.) https://doi.org/10.14341/probl13250

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).